A detailed history of Whittier Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Whittier Trust CO holds 1,368 shares of BIIB stock, worth $237,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,368
Previous 1,583 13.58%
Holding current value
$237,744
Previous $366,000 27.6%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$189.07 - $236.8 $40,650 - $50,912
-215 Reduced 13.58%
1,368 $265,000
Q2 2024

Jul 26, 2024

SELL
$190.52 - $236.72 $438,958 - $545,402
-2,304 Reduced 59.27%
1,583 $366,000
Q1 2024

May 02, 2024

SELL
$212.02 - $267.71 $44,524 - $56,219
-210 Reduced 5.13%
3,887 $838,000
Q4 2023

Jan 11, 2024

BUY
$222.59 - $267.94 $30,272 - $36,439
136 Added 3.43%
4,097 $1.06 Million
Q3 2023

Oct 27, 2023

SELL
$253.3 - $285.89 $5,572 - $6,289
-22 Reduced 0.55%
3,961 $1.02 Million
Q2 2023

Jul 24, 2023

SELL
$275.25 - $318.06 $11,835 - $13,676
-43 Reduced 1.07%
3,983 $1.13 Million
Q4 2022

Jan 25, 2023

SELL
$252.44 - $306.72 $9,592 - $11,655
-38 Reduced 0.94%
4,026 $0
Q3 2022

Oct 21, 2022

SELL
$194.69 - $268.46 $51,982 - $71,678
-267 Reduced 6.16%
4,064 $1.09 Million
Q2 2022

Jul 28, 2022

SELL
$187.54 - $223.02 $145,155 - $172,617
-774 Reduced 15.16%
4,331 $883,000
Q1 2022

Apr 29, 2022

BUY
$193.77 - $244.14 $13,370 - $16,845
69 Added 1.37%
5,105 $1.08 Million
Q4 2021

Jan 19, 2022

SELL
$223.92 - $287.77 $54,412 - $69,928
-243 Reduced 4.6%
5,036 $1.21 Million
Q2 2021

Jul 29, 2021

SELL
$259.0 - $414.71 $244,237 - $391,071
-943 Reduced 15.16%
5,279 $1.83 Million
Q1 2021

Apr 26, 2021

BUY
$242.95 - $284.63 $107,869 - $126,375
444 Added 7.68%
6,222 $1.74 Million
Q4 2020

Jan 29, 2021

SELL
$236.26 - $355.63 $188,299 - $283,437
-797 Reduced 12.12%
5,778 $1.42 Million
Q3 2020

Oct 30, 2020

SELL
$264.77 - $305.71 $25,682 - $29,653
-97 Reduced 1.45%
6,575 $1.87 Million
Q2 2020

Jul 10, 2020

SELL
$258.66 - $342.55 $121,052 - $160,313
-468 Reduced 6.55%
6,672 $1.79 Million
Q1 2020

Apr 27, 2020

SELL
$268.85 - $341.04 $95,441 - $121,069
-355 Reduced 4.74%
7,140 $2.26 Million
Q4 2019

Jan 31, 2020

BUY
$220.06 - $304.07 $152,061 - $210,112
691 Added 10.16%
7,495 $2.22 Million
Q3 2019

Oct 18, 2019

SELL
$217.44 - $243.88 $1.93 Million - $2.16 Million
-8,862 Reduced 56.57%
6,804 $1.58 Million
Q2 2019

Jul 23, 2019

SELL
$219.29 - $241.72 $181,352 - $199,902
-827 Reduced 5.01%
15,666 $3.66 Million
Q1 2019

Apr 29, 2019

BUY
$216.71 - $338.96 $91,018 - $142,363
420 Added 2.61%
16,493 $3.9 Million
Q4 2018

Feb 07, 2019

BUY
$278.5 - $352.75 $72,410 - $91,715
260 Added 1.64%
16,073 $4.84 Million
Q3 2018

Oct 23, 2018

BUY
$293.51 - $383.83 $5,576 - $7,292
19 Added 0.12%
15,813 $5.59 Million
Q2 2018

Jul 27, 2018

BUY
$257.52 - $306.91 $914,968 - $1.09 Million
3,553 Added 29.03%
15,794 $4.58 Million
Q2 2018

Jul 20, 2018

SELL
$257.52 - $306.91 $943,038 - $1.12 Million
-3,662 Reduced 23.03%
12,241 $3.86 Million
Q1 2018

May 01, 2018

SELL
$260.13 - $367.91 $1.15 Million - $1.62 Million
-4,407 Reduced 21.7%
15,903 $4.36 Million
Q4 2017

Feb 07, 2018

BUY
$307.64 - $344.58 $114,442 - $128,183
372 Added 1.87%
20,310 $6.47 Million
Q3 2017

Oct 23, 2017

BUY
$281.15 - $329.69 $5.61 Million - $6.57 Million
19,938
19,938 $6.24 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.